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The Fas/Fas Ligand Pathway and Bcl-2
Regulate T Cell Responses to Model
Self and Foreign Antigens
molecules that function to limit T cell responses by in-
ducing T cell anergy or apoptosis lead to autoimmune
diseases that are often lethal (Singer and Abbas, 1994;
Nagata and Suda, 1995; Tivol et al., 1996). Despite many
recent advances, the mechanisms by which T cell sur-
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²Department of Pathology to microbes and other foreign antigens, remain poorly
understood. Elucidating these mechanisms may lead toWashington University School of Medicine
St. Louis, Missouri 63110 rational approaches for enhancing immunological mem-
ory and for controlling autoreactivity. In this report we
examine the role of apoptosis in regulating in vivo T cell
survival and responses to different forms of antigen.Summary
The best-defined regulators of T cell apoptosis are
Fas and related proteins of the tumor necrosis factorWe have examined the role of Fas and Bcl-2 in T cell
survival and responses to antigen in vivo using T cells receptor family and molecules of the Bcl family. Fas
(CD95) induces apoptosis in many cell types (Nagatathat express a transgenic antigen receptor specific for
hen egg lysozyme (HEL) and that either lack functional and Golstein, 1995), while Bcl proteins, such as Bcl-2
and Bcl-xL, block cell death (Cory, 1995). Much workFas or Fas ligand (FasL) or overexpress Bcl-2 as a trans-
gene. HEL-specific, Bcl-2±transgenic T cells showed has focused on the molecular mechanisms by which
these molecules regulate apoptosis. Cross-linking ofprolonged responses to immunization with cognate
peptide but were eliminated rapidly when exposed to Fas results in the formation of a signaling complex that
activates a family of proteases called caspases thatHEL expressed systemically as a self antigen. In con-
trast, Fas- and FasL-defective T cells did not display are responsible for inducing apoptosis (Henkart, 1996).
Bcl-2 and Bcl-xL function to inhibit the activation of theseexaggerated responses to immunization with HEL
peptide, but did show increased expansion and sur- proteases (Cory, 1995). The molecular and functional
interactions between the Fas- and Bcl-regulated path-vival in response to systemic self antigen and were
able to activate anti-HEL (self) antibody-forming cells. ways of apoptosis are issues of some uncertainty at
present.Thus, Bcl-2 and Fas play different roles in the regula-
tion of T cell responses to antigen in vivo and in self To study the physiological role of Fas and Bcl-2 in
regulating apoptosis in primary T cells, we have bredtolerance.
mice expressing the 3A9 T cell receptor (TCR) transgene,
specific for the hen egg lysozyme (HEL) peptide 46-61
Introduction (HEL46-61) in the context of I-Ak (Ho et al., 1994), with mice
that lack functional Fas (lpr; Watanabe-Fukunaga et al.,
T cell responses and tolerance are controlled by balanc- 1992) or Fas ligand (FasL) (gld; Takahashi et al., 1994)
ing cell survival and expansion on the one hand with or with mice that express Bcl-2 as a transgene in all T
induction of apoptosis on the other. The stimuli that cells (Strasser et al., 1991). The resulting progeny in-
promote the survival, proliferation, and differentiation of clude TCR-transgenic mice in which the function of a
T cells after antigen encounter include costimulators, known regulator of apoptosis has been disrupted. In
growth factors, and differentiation-inducing cytokines. this report, we examine the survival and responses of
Following their initial activation, a small fraction of T cells from these mice in vitro and in response to a
lymphocytes differentiate into effector and memory single administration of immunogenic antigen or con-
cells, and the majority of the cells die by apoptosis. tinuously present systemic self antigen in vivo. Our
This returns lymphocyte numbers to a basal level, thus results show that Fas and Bcl-2 regulate distinct path-
maintaining homeostasis in the immune system. Such ways of apoptosis in T cells and that these pathways of
a sequence of events is characteristic of responses to apoptosis have different functions in T cell homeostasis
foreign antigens, which are usually eliminated by the and the control of T cell responses to antigen.
time the response declines.
Responses to self antigen, in contrast, either never
Resultsdevelop or are abortive and short-lived, even though
the antigen persists. Genetic defects that predispose to
Characterization of 3A9 TCR-Transgenic Miceautoimmunity are providing valuable information about
with Defective Fas/FasL and Constitutivelythe mechanisms responsible for terminating T cell re-
Expressed Bcl-2sponses to self antigens. For instance, deficiencies of
In the initial set of experiments, we defined the matura-
tion of T cells in 3A9 TCR-transgenic wild-type (3A9/1)³Present address: Department of Biology, Massachusetts Institute
and lpr, gld, and Bcl-2±expressing mice and the re-of Technology, Cambridge, Massachusetts 02139.
sponses of T cells from these mice to antigen in vitro.§To whom correspondence should be addressed (e-mail: aabbas@
bustoff.bwh.harvard.edu). 3A9/lpr and gld mice show normal maturation of T cells
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Figure 1. T Cell Populations in 3A9 Mice
Spleen cells were harvested from age-matched (8 week-old) 3A9/1, lpr, gld, and Bcl-2 mice; stained with antibodies to CD4, CD8, and the
3A9 TCR; and analyzed by flow cytometry. Numbers refer to the percentage of total cells in each quadrant.
in the thymus, identical to 3A9/1 mice (Van Parijs et al., Regulation of T Cell Apoptosis
by Fas/FasL and Bcl-21998), and a normal distribution of mature 3A9 T cells
In the next set of experiments we tested the role of Fas/in the spleen and lymph node (Figure 1). 3A9/Bcl-2 mice,
FasL and Bcl-2 in regulating apoptosis in 3A9 T cells inin contrast, have significantly increased numbers of thy-
vitro. T cells undergo cell death either when they aremocytes and mature T cells. In the spleen and lymph
deprived of growth and activation stimuli or when theynodes, there is a 3- to 4-fold increase in the frequency
are repeatedlystimulated by high concentrations of anti-of CD41 cells that express the 3A9 TCR (Figure 1 and
gen or antibodies to the TCR. The constitutive expres-data not shown). There is also a significant increase in
sion of Bcl-2 promotes the survival of naive 3A9 T cellsthe frequency of mature CD81 cells that express the 3A9
when they are cultured in the absence of activation stim-TCR. Presumably, these are cells that have rearranged
uli or growth factors (Figure 2B). In contrast, Fas- andendogenous TCR a chains and also express other, class
FasL-mutant 3A9 T cells, like wild-type 3A9 cells, rapidlyI±restricted TCRs. In all of the strains of mice, the CD41
become apoptotic under the same conditions. Similar3A9 T cells are phenotypically naive, as judged by the
results were obtained with 3A9 T cells that were firstexpression of L-selectin and CD25 (data not shown).
activated with antigen and then cultured in medium with-To assay responses to antigen, CD41 T cells were
out growth factors (data not shown). Therefore, Bcl-2purified from spleens and lymph nodes of the3A9 mouse
protects T cells from passive cell death (also calledstrains and stimulated with HEL46-61 in culture. As shown ªdeath by neglectº), while Fas is not involved in this
in Figure 2A, wild-type 3A9 T cells respond to cognate
form of cell death. Bcl-x transgenic T cells also show
peptide presented by syngeneic antigen-presenting
resistance to passive cell death (data not shown), sug-
cells (APCs) in a dose-dependent manner. Similar re- gesting that Bcl-2 and Bcl-x can function interchange-
sponses are seen with gld and Bcl-2±transgenic T cells ably when overexpressed in T cells.
after 72 hr of culture with antigen, indicating that FasL If recently activated T cells are restimulated with high
and Bcl-2 do not regulate T cell proliferation. Fas-defi- concentrations of immobilized anti-CD3 antibody, they
cient 3A9/lpr T cells show slightly depressed prolifera- undergo activation-induced cell death (AICD) (Singer
tive responses to peptide in vitro (Figure 2A), probably and Abbas, 1994). 3A9 T cells that lack functional Fas
because of the reduced amount of interleukin-2 (IL-2) or FasL are resistant to this form of cell death, whereas
secreted by these T cells (data not shown; Singer Bcl-2 transgenic 3A9 T cells, like wild-type T cells, are
and Abbas, 1994). In addition, 3A9/lpr, gld, and Bcl-2 susceptible to AICD (Figure 2C). In fact, there is no differ-
transgenic T cells can be induced to develop into helper ence in sensitivity to AICD between Bcl-2±transgenic
T cell type 1 (Th1) and Th2 populations, similar to wild- and wild-type T cells in the range of anti-CD3 concentra-
type 3A9/1 T lymphocytes, when activated in the pres- tions tested. Also, both wild-type and Bcl-2 transgenic
ence of the appropriate cytokines (IL-12 and IL-4, 3A9 T cells exhibit high-dose suppression of prolifera-
respectively) (data not shown). Thus, the absence of tion when exposed to high concentrations of peptide in
functional Fas or FasL or overexpression of Bcl-2 does vitro, a phenomenon that is known to be due to Fas-
mediated AICD and that does not occur in lpr and gldnot affect T cell differentiation in vitro.
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Figure 2. In Vitro Proliferation (A) and
Apoptosis (B±D) of 3A9 T Cells
CD41 cells were purified from the spleen and
lymph nodes of 3A9 mice and stimulated with
HEL46-61 peptide and syngeneic APCs.
(A) Proliferation was assessed at 72 hr by
[3H]thymidine incorporation. The results rep-
resent the average of triplicate wells, and the
error bars depict the standard deviations cal-
culated. The data shown are from one repre-
sentative experiment of three performed.
(B±D) CD41 cells were purified from the
spleen and lymph nodes of 3A9 mice and
either cultured in medium for 0±3 days to as-
sess the induction of passive cell death by
propidium iodide staining (B) or stimulated
with HEL46-61 peptide and syngeneic APCs for
3 days. Activated T cells were cultured for
24 hr on anti-CD3±coated wells with IL-2 to
assay AICD (C) or were coated with an anti-
body to Fas for 30 min on ice and then
cultured on anti-hamster immunoglobulin
antibody-coated wells with IL-2, to assay
anti-Fas±induced cell death (D).
T cells (Figure 2A; Singer and Abbas, 1994). To test high levels of or persistent antigenic stimulation (Stras-
ser, 1995; Van Parijs and Abbas, 1996).directly whether Bcl-2 regulates Fas-mediated apoptosis
in T cells, activated 3A9 T cells were cultured with a This experimental approach, however, does not model
physiological responses of lymphocytes to immuno-cross-linking antibody to Fas. As shown in Figure 2D,
3A9/Bcl-2 and wild-type T cells are equally sensitive to genic antigen. We therefore used an adoptive transfer
system to study the fate of small numbers of Fas/FasL-the induction of apoptosis by Fas ligation. As expected,
Fas-deficient lpr T cells cannot be killed in this assay, mutant and Bcl-2±transgenic T lymphocytes exposed
to an immunogen. This approach has been employedbut gld T cells are hypersensitive to anti-Fas±mediated
killing. This is because FasL-mutant T cells express ele- extensively to study the in vivo response of antigen-
specific T cells to immunogenic and tolerogenic formsvated levels of Fas (data not shown; Weintraub et al.,
1997). Thus, AICD is mediated by the engagement of of antigens (Kearney et al., 1994; Perez et al., 1997;
Van Parijs et al., 1997b). Limiting numbers (5 3 106 perFas by FasL on activated T cells, and Bcl-2 is not able
to protect T cells from this form of cell death. recipient) of 3A9 T cells from the different mouse strains
were adoptively transferred into nontransgenic recipi-These data confirm previously published results show-
ents. By 3 days after transfer, approximately 0.3%±0.7%ing that Bcl-2±regulated passive cell death and Fas/
of the cells in the lymph nodes or spleen of transferFasL-mediated AICD are distinct pathways of apoptosis
recipients are HEL-specific 3A9 T cells (Figure 3). Thesein normal T lymphocytes (Strasser et al., 1995; Moreno
cells are phenotypically and functionally naive, becauseet al., 1996; Van Parijs et al., 1996, 1998). Therefore, the
they express high levels of L-selectin and the intracellu-lines of 3A9 transgenic mice we have generated allow
lar ªtrackerº dye (a marker of in vivo proliferation) (Figureus to examine the physiologic roles of these pathways
3) and proliferate modestly when restimulated with cog-of apoptosis, since they are selectively defective in one
nate peptide in vitro (Figure 4A). To mimic exposure toor the other pathway.
foreign antigen, the transfer recipients were challenged
with a subcutaneous injection of HEL46-61 peptide emulsi-
Regulation of In Vivo T Cell Responses to fied in complete Freund's adjuvant (CFA). This leads to
Foreign Antigen by Fas/FasL and Bcl-2 the up-regulation of activation markers on 3A9 T cells
The role of Fas and Bcl-2 in regulating T cell responses (data not shown), in vivo proliferation (demonstrated by
to antigen has been studied primarily by treating mice lower levels of tracker dye) and expansion (Figure 3),
with polyclonal T cell mitogens, such as superantigens, and differentiation into effector cells that proliferate vig-
or by treating TCR-transgenic mice with high concentra- orously to antigen in vitro and secrete high levels of
tions of cognate peptide (Singer and Abbas, 1994; Mogil interferon-g (Figure 4A and data not shown). Therefore,
et al., 1995; Strasser et al., 1995; Van Parijs et al., 1996, the initial in vivo responses of T cells from all the 3A9
1998). This type of antigen exposure leads to the simul- mouse strains are normal, like the in vitro responses to
taneousactivation of largenumbers of T cellsand results antigen stimulation (Figure 2A).
in the elimination of antigen-specific thymocytes and To follow the fates of these T cells, transfer recipients
mature T cells in wild-type mice (Singer and Abbas, were sacrificed and assayed at different times with or
1994; Van Parijs et al., 1996, 1998). The results of these without the single immunization. By 3 days following
studies suggest that Fas, but not Bcl-2, is involved in antigen exposure, all of the 3A9 T cells expand 3- to
5-fold, and no differences are seen in the numbers ofthe elimination of mature T lymphocytes responding to
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Figure 3. In Vivo Expansion of 3A9 T Cells in Response to Immunization
3A9 T cells were adoptively transferred into normal syngeneic recipients, which were either immunized subcutaneously with HEL46-61 in CFA
(immunized) or left untreated (naive). Draining lymph node cells were harvested after 3 days, stained with antibodies to CD4 and the 3A9 TCR,
and analyzed by flow cytometry. Numbers above the dot plots refer to 3A9 T cells as a percentage of viable cells and the total number of
3A9 T cells recovered from draining lymph nodes in each group. Tracker dye was incorporated into 3A9 T cells prior to transfer and can be
detected by flow cytometry without further manipulation of the cells. The level of tracker dye decreases as the cell divides and therefore is
a measure of in vivo proliferation. Histograms depict the level of tracker in 3A9 T cells by gating on 1G121CD41 (3A9) cells. The data shown
are from one representative mouse of three to six mice analyzed per group.
3A9/1, lpr, gld, and Bcl-2 cells in immunized recipients response of antigen-specific T cells to a self antigen.
We have previously examined the roles of these mole-(Figure 5B). This confirms that Fas and Bcl-2 do not
significantly affect initial T cell activation and expansion cules in T cell responses to an endogenous self antigen
(Van Parijs et al., 1998) by breeding 3A9/1, lpr, andin response to an immunogenic antigen challenge in
vivo. At later time points after immunization, the num- Bcl-2 TCR-transgenic mice with transgenic mice that
express HEL in the serum (Goodnow et al., 1988). Micebers of wild-type and Fas- or FasL-defective 3A9 cells
in lymph nodes decrease significantly (Figure 5B), indi- that express both the 3A9 TCR and systemic HEL show
almost complete deletion of HEL-specific thymocytescating that Fas-mediated AICD does not play an obliga-
tory role in terminating responses to a model foreign and an absence of mature cells. Neither Fas deficiency
nor Bcl-2 overexpression interferes with this process,antigen. In contrast, the number of 3A9/Bcl-2 cells re-
mains elevated at these time points, suggesting that T indicating that these molecules do not regulate negative
selection of thymocytes by a self antigen (Sentman etcell responses to immunogenic antigen are limited by
passive cell death and that these responses are pro- al., 1991; Strasser et al., 1991, 1994; Van Parijs et al.,
1998).longed by maintaining the expression of Bcl-2.
The limitation of this approach is that it does not allow
analysis of the role of Fas and Bcl-2 in the responses ofRegulation of In Vivo T Cell Responses to Self
Antigen by Fas/FasL and Bcl-2 mature T cells to self antigen, because the systemically
expressed ªselfº antigen induces deletion of developingIn the next series of experiments we wanted to compare
the roles of Fas and FasL and Bcl-2 in regulation of the 3A9 thymocytes. To study responses of mature T cells
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Figure 4. In Vitro Responses of 3A9 T Cells Exposed to Immunogenic Antigen (A) or Soluble ªSelfº Antigen (B) In Vivo
(A) 3A9 T cells were adoptively transferred into normal syngeneic recipients, which were either immunized subcutaneously with HEL46-61 in
CFA (immunized) or left untreated (naive). Draining lymph node cells were harvested after 3 days and cultured with increasing concentrations
of HEL46-61 peptide.
(B) 3A9 T cells were transferred into normal mice (naive) or into recipients that express HEL in the serum (sHEL Tg). Spleen cells were harvested
on day 3 and cultured with increasing concentrations of HEL46-61 peptide. Proliferation was assessed at 72 hr by [3H]thymidine incorporation.
The results represent the average of triplicate wells, corrected for the number of 3A9 cells present per well (total proliferation 3 percentage
3A9 cells/total number of lymph node or spleen cells per well), and the error bars depict the standard deviations calculated. The data shown
are from one representative mouse of three to six mice analyzed per group.
to the ªselfº antigen, we adoptively transferred CD41 Induction of ªAutoantibodyº Responses
by Transferred Helper T Cells3A9 T cells into transgenic mice that express approxi-
mately 20ng/ml HEL in the serum (Goodnow et al., 1988). The major pathological consequence of disrupting AICD
in mice that lack functional Fas and FasL is the produc-Three days after exposure to systemic HEL, antigen-
specific T cells express activation markers and show tion of high-titer autoantibodies, predominantly of the
IgG2a isotype (Singer et al., 1994). We therefore testedproliferation and expansion in vivo (Figure 6 and data
not shown). In fact, the phenotype of 3A9 T cellsexposed whether we could induce an antibody response to HEL
(which is a model self antigen in our system) in solubleto systemic self antigen at this time point is identical to
those responding to immunogenic antigen. These cells HEL (sHEL)±transgenic recipients by adoptive transfer
of mature 3A9 T cells. Prior to transfer, mice expressingalso remain responsive to restimulation by cognate pep-
tide in vitro (Figure 4B). There are no significant differ- HEL in the serum do not contain anti-HEL antibody-
forming cells (AFCs), even after immunization with HELences in the numbers of 3A9/1, lpr, gld, and Bcl-2 T
cells present in HEL-transgenic recipients on day 3, sug- protein in adjuvant (Table 1; Goodnow et al., 1988). This
is because any HEL-specific B cells that are generatedgesting that Fas and Bcl-2 do not regulate the magnitude
of T cell activation and early expansion to systemic in these mice are probably rendered anergic (Goodnow
et al., 1988), while HEL-specific helper T cells are proba-antigen in vivo (Figure 5E). However, at later time points,
a significant decrease is seen in the numbers of wild- bly deleted in the thymus (Akkaraju et al., 1997; Van
Parijs et al., 1998). However, 14±16 days after transfertype and Bcl-2±transgenic T lymphocytes but not of
Fas- and FasL-mutant cells (Figures 5C and 5E). This of 3A9 T cells, detectable levels of anti-HEL AFCs are
found by enzyme-linked immunospot (ELISPOT) analy-suggests that responses to circulating self antigen are
limited primarily by Fas-mediated AICD and not by pas- sis in HEL-transgenic recipients. The number of anti-
HEL AFCs is modest in mice receiving 3A9/1 or Bcl-2sive cell death. The number of 3A9/lpr and gld T cells
in HEL-transgenic recipients does decrease by 16 days, cells but is significantly higher in those that received
3A9/lpr or gld cells. Importantly, only mice receiving 3A9indicating that these chronically activated T cells may
remain sensitive to other regulatory pathways. T cells lacking functional Fas or FasL have AFCs that
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Regulation of T Cell Responses and Homeostasis
by Passive Cell Death
The role of the Bcl molecules, Bcl-2 and Bcl-xL, in
blocking apoptosis in T cells is well established (Cory,
1995). The function of these anti-apoptotic members of
the Bcl protein family is regulated by their interactions
with pro-apoptotic members of the family. Recent work
suggests that the balance of interactions between pro-
and anti-apoptotic Bcl molecules may be controlled by
regulating their state of phosphorylation through sig-
nals derived from kinases that function downstream of
growth factor receptors (Datta et al., 1997; del Peso et
al., 1997).
The role of Bcl proteins in T cells in vivo has been
addressed by generating mice that overexpress these
molecules as transgenes or that have been made geneti-
cally deficient for them. Transgenic mice that constitu-
tively express Bcl-2 in T cells show progressive ac-
cumulation of thymocytes and mature T lymphocytes,
suggesting a role for this molecule in promoting T cell
survival in vivo (Strasser et al., 1991; Van Parijs et al.,
1998). T cell accumulation in thesemice occurs indepen-
dently of antigenic stimulation, for instance by environ-
mental antigens, as seen in TCR-transgenic mice that
have a very restricted T cell repertoire (Linette et al.,
1994; Van Parijs et al., 1998). In this report we show that
Bcl-2 overexpression also promotes the survival of T
cells following antigen exposure. A similar role for this
molecule in B cells is suggested by the observation that
antibody responses are prolonged in mice expressing
Figure 5. In Vivo Expansion and Survival of 3A9 T Cells in Response Bcl-2 as a transgene in B cells (Nunez et al., 1991; Smith
to Immunization or Soluble ªSelfº Antigen et al., 1994). Furthermore, the magnitude of recall anti-
Lymph node (A±C) and spleen (D and E) cells were harvested on body responses is significantly greater in these mice,
day 3, 7, or 16 from adoptive transfer recipients that were either
suggesting that Bcl-2 may play a role in establishingimmunized subcutaneously with HEL46-61 in CFA (B, immunized), or
and maintaining memory. Importantly, passive cell deathleft untreated (A and D, naive), or that expressed HEL in the serum
does not appear to be involved in maintaining self toler-(C and E, sHEL Tg); counted; and stained with antibodies to the 3A9
TCR and CD4. The number of 3A9 T cells present was determined ance, since Bcl-2±transgenic T cells behave identically
by multiplying the frequency of 3A91CD41 cells by the total number to wild-type cells in response to a model self antigen.
of cells. Data points represent individual mice, and means are de- In agreement with this, Bcl-2±transgenic mice do not
picted by horizontal lines.
contain increased numbers of autoreactive T cells and
only rarely develop autoimmune disease (Sentman et
secrete anti-HEL antibodies of the IgG2a isotype (Table al., 1991; Strasser et al., 1991; Van Parijs et al., 1998).
1). Therefore, Fas-mediated termination of T cell re- When expressed as transgenes, Bcl-2 and Bcl-x ap-
sponses to systemic antigens functions to prevent the pear to function interchangeably (Chao et al., 1995).
development of anti-self B cell responses. However, the expression of Bcl-2 appears to be consti-
tutive inperipheral T lymphocytes and is up-regulated by
Discussion cytokines that utilize the conserved common cytokine
receptor g (gc) chain of the IL-2 receptor (Akbar et al.,
The results presented in this report indicate that Fas 1996; Kondo et al., 1997). In contrast, Bcl-xL is induced
and Bcl-2 regulate distinct forms of apoptosis in primary upon T cell activation by the engagement of CD28 (Boise
T cells and that these pathways of cell death play distinct et al., 1995). Therefore, it is likely that during immune
roles in vivo. Bcl-2 protects T cells from apoptosis responses, as antigen is eliminated, the stimuli for Bcl-2
caused by the absence of growth factors and activation and Bcl-xL expression progressively decrease, resulting
stimuli, called passive cell death, and prolongs the re- in the death of the majority of responding lymphocytes,
sponse of T cells to a model foreign antigen in vivo. In and a reduction of the number of lymphocytes in periph-
contrast, Fas induces apoptosis in activated T cells that eral tissues to basal levels.
are restimulated with high concentrations of antigen or
antibodies to the TCR, by a process called AICD. In vivo,
Fas-mediated apoptosis is responsible for eliminating Regulation of T Cell Tolerance by AICD
In contrast to passive cell death, the main function ofT cells responding to a model systemic self antigen and
for preventing autoreactive helper T cells from activating AICD appears to be maintenance of self tolerance by
elimination of autoreactive lymphocytes. Mice and hu-self-reactive B cells. This pathway of apoptosis does
not function to terminate responses to foreign antigens. mans with functional defects in Fas or FasL display
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Figure 6. In Vivo Expansion of 3A9 T Cells in Response to Soluble ªSelfº Antigen
3A9 T cells were transferred into normal mice (naive) or into recipients that express HEL in the serum (soluble HEL-transgenic). Spleen cells
were harvested on day 3, stained with antibodies to CD4 and the 3A9 TCR, and analyzed by flow cytometry. Numbers in the dot plots refer
to 3A9 T cells as a percentage of viable cells and the total number of 3A9 T cells recovered from the spleen in each group. Tracker dye was
incorporated into 3A9 T cells prior to transfer and is depicted in the histograms as in Figure 3. The data shown are from one representative
mouse of three to six mice analyzed per group.
deregulated lymphocyte homeostasis and develop au- that the accumulation of autoreactive T cells in Fas- or
FasL-mutant mice is probably driven by recognition oftoimmune disease (Singer et al., 1994 Fisher et al., 1995;
Rieux-Laucat et al., 1995). We have previously shown endogenous antigens, since it is blocked by restricting
Table 1. Induction of Anti-HEL Antibody±Forming Cells in sHEL-Transgenic Mice Transferred with 3A9 T Cells
Experiment 1 Experiment 2
Total Total
Immunoglobulin IgG2a Immunoglobulin
3A9/1 36 6 17 0 59 6 4
3A9/Ipr 201 6 47 16 6 6 ND
3A9/gld 133 6 21 96 6 24 476 6 113
3A9/Bcl-2 52 6 11 0 ND
No 3A9 T cells 3 6 2 0 4 6 1
Immunized 6 6 5 0 12 6 9
Spleen cells were harvested from sHEL-transgenic mice 14±16 days after they received 5 3 106 3A9 T cells (3A9/1, lpr, gld, or Bcl-2); or were
immunized intraperitoneally with 100 mg of HEL protein in CFA (immunized); or were left untreated (no 3A9 T cells). The total number of anti-
HEL AFCs (total immunoglobulin), as well as the number of AFCs of the IgG2a isotype (IgG2a) present was determined by ELISPOT. Non-
transgenic mice that recieved 3A9 T cells did not develop anti-HEL AFCs unless immunized with HEL (data not shown). The values represent
the mean number of AFCs detected per 5 3 105 spleen cells (two mice per group, assayed in duplicate), and the errors represent the standard
deviations calculated.
ND, not done.
RE
TR
AC
TE
D
Immunity
272
the TCR repertoire (Singer and Abbas, 1994; Van Parijs Finally, our results show that Fas-mediated AICD is
important for eliminating T cells reactive against a dis-et al., 1998). The results presented here demonstrate
seminated self antigen. We do not know if the samedirectly that Fas is responsible for eliminating mature T
pathway will be involved in tolerance to tissue antigens.cells that respond to a model systemic self antigen.
In fact, we and others have postulated that toleranceThis observation is consistent with the notion that the
against tissue-restricted self antigens may be largelyprincipal role of Fas is to mediate the deletion of mature
due to functional anergy, perhaps mediated by CTLA-4T cells (Singer and Abbas, 1994). Fas is not critically
(Perez et al., 1997), whereas AICD is most importantinvolved in eliminating self-reactive thymocytes, since
for tolerance to widely disseminated or abundant selfnegative selection occurs normally in Fas-deficient HEL-
antigens. Studies are currently underway to test thesespecific TCR-transgenic mice that express HEL in the
hypotheses formally, using transgenic mice expressingserum (Akkaraju et al., 1997; Van Parijs et al., 1998).
TCRs specific for antigens expressed in tissues or inA major consequence of disrupting Fas-mediated
the circulation.elimination of T cells is the activation of autoreactive B
The use of an adoptive transfer system, utilizing Tcells. Theautoimmune pathology associated with defec-
cells from TCR transgenic mice with selective defectstive AICD, in humans and mice, is mediated by self-
in one of two pathways of apoptosis, providesan experi-reactive antibodies. The results presented in this paper
mental model for analyzing the control and physiologicdemonstrate directly that AICD-resistant helper T cells
roles of lymphocyte apoptosis. It follows, from our stud-are able to activate autoreactive B cells. In fact, even
ies, that manipulatingBcl-2±regulated passive cell deathself-reactive B cells that are rendered anergic by expo-
may be most valuable for prolonging memory responsessure to autologous antigens may be induced to prolifer-
to vaccines, whereas regulating Fas-mediated AICDate and differentiate if provided sufficient T cell help
may be important for controlling responses to persistent(Cooke et al., 1994).
and disseminated antigens, such as self antigens. It
remains to be seen if these concepts are applicable toRegulating Responses to Antigen: What Are
manipulating immune responses to tumors and tissuethe Determining Factors?
transplants, as well.The key conclusion of our study, that responses to for-
eign antigens are controlled by passive cell death and
Experimental Proceduresthose against self antigens by AICD, raises an important
question: what are the differences between foreign and Mice
self antigens that result in the triggering of distinct death All mice used were 6±8 weeks old and were maintained in accor-
dance with the guidelines of the Committee on Animals of Harvardpathways? Likely differences between foreign and self
Medical School and those of the Committee of Care and Use ofantigens are the concentration and persistence of avail-
Laboratory Animals of the Institute of Laboratory Animal Resources,able antigen, which influence the frequency of antigenic
National Research Council. Mice expressing the transgenic 3A9
stimulation. Thus, immunization with antigen in adjuvant TCR, specific for HEL46-61 1 I-Ak (Ho et al., 1994), were kindly provided
(the model for foreign antigen) may result in short-lived by M. Davis (Stanford University, Palo Alto, CA), and transgenic
mice expressing approximately 20 ng/ml of HEL in the serum (sHELstimulation, because the concentration of antigen ex-
Tg, Goodnow et al., 1988) were a generous gift from C. Goodnowpressed in lymphoid tissues is relatively low and it is
(John Curtin Shool of Medical Research, Canberra, Australia). Micerapidly eliminated by the specific immune response.
expressing human Bcl-2 under the control of the EmPm promoter
This may be insufficient for triggering the Fas pathway. element in T cells (Strasser et al., 1991) were purchased from Jack-
Under these conditions, as the antigen is eliminated, son Laboratory. The breeding schemes used to obtain 3A9 TCR-
activated lymphocytes lose expression of Bcl-2 and Bcl- transgenic mice that lack functional Fas (3A9/lpr) or FasL (3A9/gld)
or that overexpress Bcl-2 in T cells (3A9/Bcl-2) and sHEL-transgenicxL and undergo passive cell death. In contrast, circulat-
mice of the appropriate genetic background have been describeding ªselfº antigen cannot be eliminated and is present
previously (Van Parijs et al., 1998).at higher concentrations. This may lead to repeated T
cell stimulation, sufficient to trigger Fas-mediated AICD, Genotyping
which is a dominant pathway of apoptosis. Consistent The genotype of all mice used was determined by PCR analysis of
tail DNA. The primers used to identify the 3A9, Bcl-2, and sHELwith this idea, the sensitivity of primary T cells to Fas-
transgenes and lpr mice have been describe elsewhere (Singer andmediated apoptosis is promoted by the presence of
Abbas, 1994; Van Parijs et al., 1998). A novel PCR assay was devel-elevated levels of IL-2 (Lenardo, 1991; Van Parijs et al.,
oped to screen gld mice. The PCR primers used were p39 59 TCT
1997a; Y. Refaeli et al., unpublished data), which might CAA CTC TCT CTG ATC AAT TTT GAG GAA TCT AAG GCC 39 and
not be attained if the local antigen concentration is p24 59 CTC TCA TTC AAG ACA ATA TTC CTG 39. The p39 primer
is designed to create a StuI restriction site with wild-type FasL (TTT)too low.
but not with gld FasL (CTT). PCR amplification of gld FasL followedFactors other than antigen persistence and concen-
by StuI digestion results in a single band of 135 bp, while bands oftration may also influence which pathway of apoptosis
96 bp and 39 bp are obtained with wild-type FasL (data not shown).
is active. For instance, the inflammation associated with The PCR amplification cycle was as follows: 948C for 2 min; 50
adjuvants may block AICD (Vella et al., 1995), allowing cycles of 948C for 1 min, 518C for 1 min, and 728C for 1 min; 728C
an immune response to develop and to persist until for 7 min; and a 48C soak. Digestion with StuI was performed at
378C for 2 hr with 8 ml of PCR product, 2 ml of NEBuffer 2 (Newsufficient antigenhas been cleared for passive cell death
England Biolab), 1.5 ml of StuI (10 U/ml, New England Biolab), andto become active, thus terminating the response. The
8.5 ml of distilled H2O per reaction.anatomy of antigen recognition is also different for sub-
cutaneously administered immunogenic antigen (drain- Phenotypic Analysis of TCR-Transgenic Mice
ing lymph nodes) and circulating self antigen (dissem- The frequency and phenotype of lymphocytes in 3A9 mice were
determined by staining an aliquot of 106 viable cells. The monoclonalinated).
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antibodies (mAbs) used were fluorescein isothiocyanate (FITC)± were visualized by adding a 1:4 mix of agarose in distilled H2O
containing 1.25 mg/ml BCIP in AMP buffer (1 M 2-amino-2-methyl-conjugated anti-CD8, Cy-Chrome C±conjugated anti-CD4 (both
from PharMingen, San Diego, CA), and biotinylated 1G12 mAb (spe- L-propanol [pH 10.2]).
cific for the 3A9 TCR), followed by phycoerythrin-conjugated strep-
tavidin (PharMingen). The 1G12 mAb was made by immunizing Acknowledgments
CB.17 mice with T cells from 3A9 TCR-transgenic mice. Hybridomas
were screened by stimulation of the 3A9 T cell hybridoma, and the We thank Chris Goodnow (John Curtin School of Medical Research,
specificity of the 1G12 antibody was confirmed by binding to 3A9 Canberra, Australia) and Mark Davis (Stanford University School
TCR-transgenic T cells but not to T cells from nontransgenic CBA of Medicine, Palo Alto, CA) for generous gifts of transgenic mice;
or B10.BR mice. The characteristics of this antibody will be de- Alexander Ibraghimov for developing the diagnostic PCR assay for
scribed in more detail separately (D.A.P. and E. R. Unanue, unpub- gld mice; Cheryl London for help with adoptive transfer experiments;
lished data). Stained cells were analyzed on a FACScan flow cyto- and Dr. London and Yosef Refaeli for helpfuldiscussions. Supported
meter (Becton Dickson, San Francisco, CA). by National Institutes of Health grants AI35297 and AI32531 (A. K. A.)
and AI22033 (D. A. P.), and National Institutes of Health training
In Vitro Proliferation and Differentiation Assays grant HL07627 (L. V. P.).
Spleen cells from 3A9 mice were harvested, and CD41 T cells were
purified using CD4 Dynabeads (Dynal AS, Oslo, Norway). T cell Received November 7, 1997; revised December 23, 1997.
preparations were typically greater than 98% CD41 as determined
by staining and flow cytometry. To measure proliferative responses
Referencesto antigen, 2 3 104 3A9 T cells were cultured in 0.2 ml of RPMI
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